ST岭南公告称，"岭南转债"无法按期兑付本息，其信用等级被下调为C。公司近年业务受冲击，营收持 续下滑，2024年营收8.62亿元，同比降59.55%，净亏9.84亿元，亏损缩窄9.86%；2025年1 - 9月营收2.53 亿元，同比降68.75%，净亏2.06亿元，亏损缩窄23.34%。公司还面临持续经营、增信计划抵质押资产变 现、股票退市、诉讼等风险。近日，因金融借款合同纠纷，公司和子公司被列为第三人涉诉，案件未开 庭，影响未知。 ...

Core Viewpoint - Semilux International Ltd. has received a deficiency notice from Nasdaq regarding its Market Value of Listed Securities, which fell below the required minimum of $35 million, impacting its compliance status for continued listing on the Nasdaq Global Market [1][2]. Group 1: MVLS Deficiency Notice - The MVLS Deficiency Notice indicates that from November 13, 2025, to December 30, 2025, the Company's MVLS was below the $35 million threshold required for Nasdaq listing [1]. - The notice does not immediately affect the trading of the Company's ordinary shares, which continue to trade under the symbol "SELX" [2]. Group 2: Compliance Timeline - The Company has until June 29, 2026, to regain compliance with the MVLS Requirement, as per Nasdaq Listing Rule 5810(c)(3)(C) [2]. - To regain compliance, the Company's MVLS must close at $35 million or more for at least ten consecutive business days during the compliance period [2]. Group 3: Potential Delisting - If compliance is not achieved by the Compliance Date, Nasdaq will issue a notice regarding potential delisting, which the Company can appeal [3]. - There is no guarantee that any appeal against a delisting determination would be successful [3]. Group 4: Company Actions - The Company plans to actively monitor its MVLS and will take reasonable measures to regain compliance with the MVLS Requirement [4]. - Despite the Company's efforts to maintain its listing, there is no assurance that it will successfully regain or maintain compliance with Nasdaq's continued listing standards [4].

最新公告列表 《关于公司股票可能被终止上市的风险提示公告》 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 截至2026年1月7日收盘，*ST长药（300391）报收于0.84元，较前一交易日下跌4.55%，最新总市值为 2.94亿元。该股当日开盘0.87元，最高0.88元，最低0.83元，成交额达3535.92万元，换手率为11.85%。 近日，长江医药控股股份有限公司发布关于公司股票可能被终止上市的风险提示公告。公告显示，公司 股票可能因交易类、财务类及重大违法情形被终止上市。公司股票收盘市值已低于3亿元，股价连续五 个交易日低于1元，存在交易类退市风险。2024年末净资产为负，2025年三季度末净资产继续为负，若 2025年度经审计净资产为负或财务报告被出具非标意见，将触发财务类退市。公司因2021至2023年年度 报告存在虚假记载，已被证监会立案并下发行政处罚事先告知书，可能触及重大违法强制退市。此外， 公司存在大额债务逾期、银行账户被冻结、子公司破产等风险。 ...

*ST岩石公告称，近日公司股价波动较大且于2025年某日涨停，此前已多次披露异常波动及澄清公告。 截至公告披露日，公司及控股股东无应披露未披露重大事项。2025年前三季度，公司营收3476.21万 元，净利润-1.12亿元。若2025年度相关指标不达标或财报被出具非标意见，公司股票将触及财务类退 市情形。此外，控股股东股份全部被司法冻结，实控人韩啸已被采取刑事强制措施，提醒投资者注意交 易风险。 ...

*ST正平9月以来累计26个交易日涨停。其间，该股三度停牌核查。 近期，有债权人申请对*ST正平预重整，截至本公告披露日，公司尚未收到法院关于受理预重整申请的相关法律文书，即申请人的预重整申请能否 被法院受理、公司能否进入重整程序均存在重大不确定性，公司提醒广大投资者注意相关投资风险。 *ST正平同时提到，公司近期收到上交所对公司2025年三季报有关事项的监管工作函。截至目前，年审会计师尚无法就外部借款利息、工程项目成 本费用计量准确性和完整性获取充分、恰当的审计证据。"如截至2025年度财务报告日，年审会计师仍无法就上述事项获取充分、恰当的审计证 据，可能导致无法对财务报表发表非无保留意见，公司股票将被终止上市。" 矿产资源开采能力不足，也是目前*ST正平面临的难题。公司全资子公司格尔木生光矿业开发有限公司（以下简称"生光矿业"）取得了青海省自然 资源厅颁发的《采矿许可证》。矿产资源开发未来需大规模投入建设和运营，但公司目前无充足资金、人员及设备等用于后续开采，矿产资源后 续开采进展、能否产生收益均存在重大不确定性。*ST正平表示，截至2025年9月30日，公司货币资金为7237.67万元，其中因农民工专户 ...

人民财讯11月24日电，*ST苏吴（600200）11月24日公告，公司股票价格近四日连续涨停，最近四个交 易日公司股票价格涨幅达到21.65%，可能存在市场情绪过热及非理性炒作迹象，积累了较大交易风 险。公司股票目前存在重大违法强制退市、财务类退市、面值退市等多重退市风险，投资者在买入公司 股票前，应当认真阅读本公告及公司已披露的其他信息，充分了解股票可能被终止上市的风险，买入公 司股票的投资者将承担公司股票可能被终止上市的全部风险，包括但不限于投资损失无法获得赔偿，请 投资者审慎做出投资决策。 ...

Core Viewpoint - Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. faces significant risks of forced delisting due to major violations of laws and regulations related to information disclosure and financial reporting [2]. Group 1: Stock Performance - As of October 24, 2025, *ST Wuzhong (600200) closed at 1.06 yuan, up 4.95% from the previous trading day, with a total market capitalization of 754 million yuan [1]. - The stock opened at 1.02 yuan, reached a high of 1.06 yuan, and a low of 1.01 yuan, with a trading volume of 68.282 million yuan and a turnover rate of 9.13% [1]. Group 2: Regulatory Issues - The company was investigated by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure, leading to a formal investigation initiated on February 26, 2025 [2]. - On July 13, 2025, the company received a notice of administrative penalty, indicating that it engaged in trade activities with subsidiaries and related companies that lacked commercial substance, resulting in inflated revenue, costs, and profits in annual reports from 2020 to 2023 [2]. - The stock has been subject to multiple delisting risks, including major violations, financial issues, and face value concerns, since July 14, 2025 [2]. Group 3: Financial Performance - The company reported a net profit of -44.4178 million yuan for the first half of 2025, showing a significant decline year-on-year [2]. - As of the end of 2023, non-operating funds occupied by related parties of the controlling shareholder amounted to 1.6926071 billion yuan, which remains unresolved [2]. - The financial report for the year 2024 received a disclaimer of opinion, triggering financial delisting risk warnings [2].

Core Points - *ST Yuancheng (603388) closed at 1.9 yuan on September 18, 2025, with no change in price and a turnover rate of 11.41% [1] - The company faces significant risks of forced delisting due to allegations of false financial disclosures in its annual reports, with the China Securities Regulatory Commission (CSRC) having initiated an investigation [1][3] - The company reported a half-year revenue of 82.34 million yuan and a net loss of 126.80 million yuan for 2025, indicating ongoing financial difficulties [1] - The company has experienced continuous losses over the past three years, raising concerns about its ability to continue as a going concern [1] - There are liquidity risks due to difficulties in customer payments, and the company has overdue unused raised funds totaling 171.60 million yuan [1] - The controlling shareholder's shares are highly pledged and frozen, with some shares already auctioned or set for auction [1] - The company plans to transfer 51% of its stake in Silicon Precision Electronics, but the completion of this transaction is uncertain [1] Trading Information - On September 18, 2025, the net outflow of main funds was 6.96 million yuan, accounting for 9.66% of the total transaction amount [1][3] - Retail investors contributed a net inflow of 5.51 million yuan, representing 7.65% of the total transaction amount [1]

Core Viewpoint - The company, Lingnan Ecological Culture and Tourism Co., Ltd., is facing significant financial difficulties, including the inability to repay its convertible bonds on time, which may lead to further legal and operational challenges [2][4][6]. Financial Performance - In 2024, the company's operating revenue was 861.84 million yuan, a decline of 59.55% compared to 2023 [3]. - The net profit attributable to the parent company for 2024 was -984.33 million yuan, indicating a reduction in the scale of losses compared to 2023 [3]. - For the first half of 2025, the net profit attributable to the parent company was -128.27 million yuan, a 50.02% improvement from the same period in 2024 [3]. Debt and Credit Risks - The credit rating of the company's convertible bonds, "Lingnan Convertible Bonds," has been downgraded to C, indicating a high risk of default [2]. - The company is experiencing liquidity pressure due to delayed project payments and high debt levels, which may affect its ability to secure future financing [2][4]. Legal and Regulatory Issues - The company is involved in multiple lawsuits, with 251 pending cases as of December 31, 2024, amounting to 2.95 billion yuan in claims [7]. - A recent court ruling has been made against the company in a loan dispute, which may further complicate its financial situation [8]. Asset Pledge and Collateral Risks - The company has pledged its assets as collateral for the convertible bonds, but the realizable value of these assets is uncertain due to the nature of the receivables and the need for internal approvals [5][6]. - There is a risk that if the company faces bankruptcy within a year of the collateral establishment, the pledge may be revoked [5]. Stock Market Risks - The company's stock is at risk of being delisted if its share price remains below 1 yuan for 20 consecutive trading days, which could further erode investor confidence [6].

Group 1 - The company, Fujian Zitian Media Technology Co., Ltd., has been ordered by the Fujian Securities Regulatory Bureau to correct its financial reports due to false records, with a deadline of 30 days from the receipt of the decision [1][2] - As of now, the company has not hired a qualified accounting firm nor submitted a rectification report to the Fujian Securities Regulatory Bureau [1][2] - The company's stock has been placed under delisting risk warning since May 20, 2025, and if the rectification is not completed by July 19, 2025, the stock will be terminated from listing [1][2] Group 2 - The company received a notice on June 27, 2025, indicating potential administrative penalties for suspected violations of information disclosure laws [2] - The investigation revealed that the company's annual reports for 2022 and 2023 contained false records, with a total false revenue amounting to approximately 2.5 billion yuan, which exceeds 50% of the total reported revenue for those years [2]